Tracy Stewart is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of pharmaceutical compositions, holding 2 patents that focus on innovative formulation processes. Her work has the potential to enhance therapeutic treatments for both animals and humans.

Latest Patents

Tracy Stewart's latest patents include formulations for stable pharmaceutical compositions of recombinant beta-interferon and recombinant interleukin-2. The first patent describes a process for preparing stable pharmaceutical compositions suitable for parenteral administration, which includes a therapeutically effective amount of recombinant IFN-beta protein dissolved in an inert carrier medium. This medium comprises biocompatible non-ionic polymeric detergents, which serve as solubilizers and stabilizers. The compositions can be in liquid form or lyophilized. The second patent focuses on stable pharmaceutical compositions of recombinant interleukin-2, also designed for parenteral administration, utilizing similar biocompatible non-ionic polymeric detergents for solubilization and stabilization.

Career Highlights

Throughout her career, Tracy Stewart has worked with notable companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Cetus Corporation. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical formulations.

Collaborations

Tracy has collaborated with esteemed professionals in her field, including Ze'ev Shaked and James W. Thomson. These collaborations have further enriched her research and development efforts in pharmaceutical compositions.

Conclusion

Tracy Stewart is a trailblazer in the realm of pharmaceutical innovations, with her patents paving the way for advancements in therapeutic treatments. Her work exemplifies the impact of dedicated inventors in improving healthcare solutions.